La cadena de opciones muestra datos clave de las opciones de acciones de BioCardia a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para BioCardia..

BioCardia (NASDAQ:BCDA) Bolsa, Cadena de Opciones

BioCardia

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

BioCardia Inc

News

ANTE

AirNet Technology Announced The Execution Of A Non-binding Investment Letter Of Intent With LLP STH Corp, A Kazakstan Company

Contracts

Nokia Has Been Selected By Hetzner To Upgrade Its Data Center And Core Network Infrastructure

Nokia Announced That Worldstream Will Use Nokia's Network Security Technology To Protect Businesses In The Netherlands And Globally Against Large-scale DDOS Attacks

U.S. stocks settled higher on Friday, with the S&amp;P 500 surging more than 2% during the session.
Despite Friday's gains, stocks recorded losses last week. The Dow dipped around 3.1% to record its worst week since March 2023. The S&amp;P 500 dipped more than 2%, recording its fourth straight losing week.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst&#8217;s opinion to trust.
Benzinga&#8217;s Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. One of the ways traders can sort through Benzinga&#8217;s extensive database of analyst ratings is by analyst accuracy. Here&#8217;s a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock</a> Ratings.
Analyst: Trevor Walsh
<ul>
<li>Analyst Firm: Citizens Capital Markets</li>
<li>Ratings Accuracy: 85%</li>
<li>Latest Rating: Reiterated a Market Perform rating on Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) on March 14.</li>
<li>Recent News: On March 15, Rocket Lab USA announced its third Pioneer spacecraft for Varda Space Industries, Inc. is successfully operating on orbit.</li>
</ul>
Analyst: Mark Hughes
<ul>
<li>Analyst Firm: Truist Securities</li>
<li>Ratings Accuracy: 83%</li>
<li>Latest Rating: Maintained a Hold rating on James River Group Holdings, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) and cut the price target from $6 to $5 on March 11. This analyst sees around 25% surge in the stock.</li>
<li>Recent News: On March 4, James River Group reported worse-than-expected fourth-quarter EPS results.</li>
</ul>
Analyst: Rob Owens 
<ul>
<li>Analyst Firm: Piper Sandler</li>
<li>Ratings Accuracy: 82%</li>
<li>Latest Rating: Maintained an Overweight rating on SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) and cut the price target from $32 to $28 on March 13. This analyst sees around 52% upside in the stock.</li>
<li>Recent News: On March 12, SentinelOne reported fourth-quarter revenue of $225.5 million, beating the consensus estimate of $222.25 million, according to Benzinga Pro.</li>
</ul>
Analyst: Aaron Rakers
<ul>
<li>Analyst Firm: Wells Fargo</li>
<li>Ratings Accuracy: 82%</li>
<li>Latest Rating: Maintained an Overweight rating on Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) and cut the price target from $140 to $130 on March 13. This analyst sees around 29% upside in the stock.</li>
<li>Recent News: On March 5, Micron named Mark Liu and Christie Simons to Board of Directors.</li>
</ul>
Analyst: Alexander Paris
<ul>
<li>Analyst Firm: Barrington Research</li>
<li>Ratings Accuracy: 81%</li>
<li>Latest Rating: Maintained an Outperform rating on HealthEquity, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) with a price target of $112 on March 14. This analyst sees around 15% upside in the stock.</li>
<li>Recent News: On Feb. 18, HealthEquity affirmed guidance for fiscal 2025 and 2026.</li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44326690/top-3-materials-stocks-that-may-collapse-in-march">Top 3 Materials Stocks That May Collapse In March</a></li>
</ul>

Earnings

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

JRVR

RKLB

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

Full Year&nbsp;of 2024 Financial Highlights
<ul>
<li>Net revenues from sales of batteries were $136.59 million, an increase of 2.7% from $132.99 million in the same period of 2023.
<ul>
<li>Net revenues from batteries used in light electric vehicles were $10.32 million, an increase of 84% from $5.61 million in the same period of 2023.</li>
<li>Net revenues from batteries used in electric vehicles were $1.68 million, a decrease of 41.67% from $2.88 million in the same period of 2023.</li>
<li>Net revenues from residential energy supply &amp; uninterruptible supplies were $124.59 million, an increase of 0.1% from $124.5 million in the same period of 2023.</li>
</ul>
</li>
<li>Gross margin for the battery business was 31.5%, an increase of 7.7 percentage points from 23.8% in the same period of 2023.</li>
<li>Net income from the battery business was $19.43 million, an increase of 39.08% from $13.97 million in the same period of 2023.</li>
</ul>

CBAT

CBAK Energy Tech 2024 GAAP EPS $0.13 Up From $(0.03) YoY, Revenue $176.614M Down From $204.438M YoY

Former Nissan Motor Co. chief Carlos Ghosn claims his 18 years of work at the struggling Japanese automaker have been &#8220;wasted&#8221; while suggesting Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk could potentially fix the company&#8217;s mounting problems.
What Happened: Speaking from his home in Beirut, Lebanon, the fugitive former executive told Shukan Post that Nissan&#8217;s current leadership lacks &#8220;vision, decision, clarity, judgment, insight&#8221; following his dramatic 2018 arrest and subsequent escape from Japan.
&#8220;All the work I and my team did there over 18 years is wasted,&#8221; Ghosn said in the interview, as Nissan continues to struggle financially, having burned through ¥506 billion ($6.6 billion) in the first nine months of the fiscal year despite holding ¥1.2 trillion ($15.65 billion) in net cash, <a href="https://japantoday.com/category/features/kuchikomi/ghosn-says-all-his-work-wasted-at-nissan-says-musk-could-fix-automaker">reported</a> Japan Today
When asked what he would do if still in charge, Ghosn mentioned &#8220;My friend Elon Musk,&#8221; suggesting the world&#8217;s richest man could help turn around the automaker&#8217;s fortunes.
Nissan did not immediately respond to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44350873/nvidia-faces-new-ai-challenge-as-chinese-start-up-unveils-framework-to-cut-reliance-on-its-gpus">Nvidia Faces New AI Challenge As Chinese Start-Up Unveils Framework To Cut Reliance On Its GPUs</a>
Why It Matters: The comments come as Honda Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) reportedly remains open to reviving merger talks with Nissan that could create the world&#8217;s <a href="https://in.benzinga.com/markets/equities/25/02/43771894/honda-open-to-reviving-nissan-merger-talks-if-ceo-uchida-steps-down-creating-fourth-largest-global-automaker">fourth-largest automaker</a>, but only if current Nissan CEO Makoto Uchida steps down. Previous negotiations collapsed when Honda demanded full ownership rather than an equal partnership.
Meanwhile, Renault (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RNLSY#OTC">RNLSY</a>), which owns 36% of Nissan, is exploring options to sell its stake at a premium, while other potential investors including Foxconn, KKR &amp; Co. and U.S. automakers evaluate opportunities.
Ghosn, who rescued Nissan from near bankruptcy in 1999 by cutting 21,000 jobs and closing five plants, maintains he was a victim of Japan&#8217;s &#8220;corrupt&#8221; justice system. After spending 108 days in detention following financial misconduct charges, he escaped Japan in December 2019 hidden inside a box on a private jet.
&#8220;I have no regrets regarding my escape,&#8221; Ghosn told Shukan Post. &#8220;The treatment I received at the hands of prosecutors was cruel, inhuman and unfair.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44349818/warren-buffett-dumped-nearly-70-of-apple-shares-but-its-price-to-sales-ratio-remains-elevated-at-8-2x-warns-this-market-analyst">Warren Buffett Dumped Nearly 70% Of Apple Shares, But Its Price-To-Sales Ratio Remains Elevated At 8.2x, Warns This Market Analyst</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Tech

RNLSY

TSLA

Elon Musk As Nissan's Fix? Carlos Ghosn Says Automaker Lacks 'Vision, Decision, Clarity, Judgment, Insight'

<h3>Companies Reporting Before The Bell</h3>
• Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is expected to report quarterly earnings at $1.68 per share on revenue of $597.66 million. 
• LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $23.55 million. 
• NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) is likely to report earnings for its fourth quarter. 
• CBAK Energy Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAT#NASDAQ">CBAT</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $50.11 million. 
• Protalix BioTherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLX#AMEX">PLX</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $20.21 million. 
• NextPlat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPL#NASDAQ">NXPL</a>) is projected to report earnings for its fourth quarter. 
• Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) is projected to report quarterly earnings at $2.07 per share on revenue of $1.81 billion. 
• Inspired Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSE#NASDAQ">INSE</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $81.72 million. 
• Sonida Senior Living (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNDA#NYSE">SNDA</a>) is projected to report earnings for its fourth quarter. 
• Coda Octopus Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODA#NASDAQ">CODA</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $5.74 million. 
• Niu Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) is likely to report earnings for its fourth quarter. 
• Townsquare Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSQ#NYSE">TSQ</a>) is expected to report quarterly earnings at $0.58 per share on revenue of $116.41 million. 
<h3>Companies Reporting After The Bell</h3>
• DiaMedica Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) is likely to report earnings for its fourth quarter. 
• Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) is expected to report earnings for its fourth quarter. 
• High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) is estimated to report earnings for its first quarter. 
• Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) is expected to report earnings for its fourth quarter. 
• Health In Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIT#NASDAQ">HIT</a>) is estimated to report earnings for its first quarter. 
• Sangamo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) is likely to report earnings for its fourth quarter. 
• Open Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $24.03 million. 
• Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) is expected to report quarterly loss at $0.11 per share on revenue of $42.51 million. 
• Natural Gas Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGS#NYSE">NGS</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $40.84 million. 
• Hyperfine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>) is projected to report quarterly loss at $0.14 per share on revenue of $3.77 million. 
• FinVolution Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>) is likely to report earnings for its fourth quarter. 
• FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) is expected to report quarterly loss at $0.20 per share on revenue of $24.91 million. 
• Vicarious Surgical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBOT#NYSE">RBOT</a>) is likely to report earnings for its fourth quarter. 
• Bakkt Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) is likely to report quarterly loss at $1.25 per share on revenue of $21.61 million. 
• B. Riley Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RILY#NASDAQ">RILY</a>) is estimated to report earnings for its fourth quarter. 
• Consolidated Water Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) is likely to report quarterly earnings at $0.28 per share on revenue of $33.60 million. 
• RF Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RFIL#NASDAQ">RFIL</a>) is expected to report earnings for its first quarter. 
• Harrow (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) is estimated to report quarterly earnings at $0.07 per share on revenue of $59.09 million. 
• Hallador Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNRG#NASDAQ">HNRG</a>) is likely to report quarterly loss at $0.05 per share on revenue of $102.46 million. 
• Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $46.55 million. 
• Getty Images Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $244.87 million. 
• Lithium Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAR#NYSE">LAR</a>) is expected to report quarterly loss at $0.04 per share on revenue of $48.40 million. 
• Quanterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTRX#NASDAQ">QTRX</a>) is projected to report quarterly loss at $0.22 per share on revenue of $35.55 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMPS

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLTE

CODA

CWCO

DMAC

FGEN

FINV

GETY

HITI

HNRG

HROW

HYPR

INSE

KODK

LNZA

LPRO

NRGV

NRXP

NXPL

QFIN

QTRX

RBOT

RFIL

RILY

SAIC

SGMO

SNDA

Earnings Scheduled For March 17, 2025

The S&amp;P 500 index jumped over 2% on Friday, after a fall into the correction zone on Thursday last week, whereas the Nasdaq continues to be in the correction territory. While technical analysis points toward bearish trends, this analyst says that investors can start looking for buy signals.
What Happened: As of Friday, the S&amp;P 500 index was 8.27% down from its 52-week high, which followed a bounce from Thursday&#8217;s 10.18% drawdown. Similarly, Nasdaq 100 was 11.33% lower from its 52-week high as of Friday.
According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> and <a href="https://www.benzinga.com/report/SPY">Edge Rankings</a>, the technical analysis of the exchange-traded fund tracking the S&amp;P 500 index, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) were flashing warning signals.
Despite that Jay Kaeppel, the senior market analyst at SentimenTrader via his Panic/Euphoria analysis model showed that the S&amp;P 500&#8217;s decline was still not flashing a buy signal. However, from this point, investors could "Start looking for a buy signal".
According to the chart shared by him, when the Panic/Euphoria line falls below the Excessive Pessimism level, investors could expect a bounce back with an average of over 7% return after two months and 28% returns after a year. But, this follows a series of red dots representing that investors should take a backseat.
Hence, as his model shows the presence of only one red dot, Kaeppel doesn&#8217;t forecast a buy yet, but the start of a potentially emerging buy signal.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Is this a "Buy" signal? IMO, no. Is this a "Start looking for a buy signal" signal? IMO, yes. Doesn't mean it will come soon or that things can't get worse as the first "dot" rarely marks the exact bottom (only in 2018). Still, the numbers are what they are. <a href="https://twitter.com/sentimentrader?ref_src=twsrc%5Etfw">@sentimentrader</a> <a href="https://t.co/6Xq1lk9kNj">pic.twitter.com/6Xq1lk9kNj</a>
&mdash; Jay Kaeppel (@jaykaeppel) <a href="https://twitter.com/jaykaeppel/status/1900529743218286779?ref_src=twsrc%5Etfw">March 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/03/44350479/warren-buffett-plans-to-sell-his-real-estate-brokerage-but-its-not-a-bet-against-us-home-prices-says-analyst-as-f">Warren Buffett Plans To Sell His Real Estate Brokerage, But It&#8217;s &#8216;Not… A Bet Against US Home Prices,&#8217; Says Analyst As Fed Expects To Keep Rates Unchanged</a>
Why It Matters: SPY fell below its 200-day moving average on Thursday after its longest-ever streak and its technical charts showed that it was below all its short and long-term moving averages. The MACD momentum indicator was negative 11.38, signaling a downtrend in the short-term and its relative strength index of 37.72 was in the neutral zone.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034721/SPY-tech-chart-1024x576.png" alt="" class="wp-image-826695" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034721/SPY-tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034721/SPY-tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034721/SPY-tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034721/SPY-tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034721/SPY-tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Similarly, the Edge Rankings showed that SPY had a poor price trend in short, medium, and long term, with a momentum ranking of 64.34 percentile.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/report/SPY"><img loading="lazy" decoding="async" width="799" height="138" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034654/Edge-rankings.png" alt="" class="wp-image-826692" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034654/Edge-rankings.png 799w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034654/Edge-rankings-300x52.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/17034654/Edge-rankings-768x133.png 768w" sizes="(max-width: 799px) 100vw, 799px" /></a></figure>
Price Action: The SPY and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose on Friday. The SPY advanced 2.07% to $562.81, and the QQQ also jumped 2.42% to $479.66, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44298732/nvidia-valuation-drops-after-2025-rout-ai-chipmakers-price-declines-41-from-its-peak-when-chatgpt-was-launched" target="_blank" rel="noreferrer noopener">Nvidia Valuation Drops After 2025 Rout: Chipmaker's Price Declines 41% From Its Peak When ChatGPT Was Launched</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Market Summary

S&P 500 Price Trend Flashes Warning Signals But This Expert Says 'Start Looking For A Buy Signal' After Last Week's Drawdown

Guidance

Niu Technologies Sees FY25 Sales Volume Of 1.3M - 1.6M Units

Niu Technologies Sees Q1 Revenue Of RMB 631M - RMB 707M

Niu Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIU#NASDAQ">NIU</a>) reported quarterly losses of $(0.06) per share. This is a 73.91 percent increase over losses of $(0.23) per share from the same period last year. The company reported $112.23 million in sales this quarter. This is a 66.46 percent increase over sales of $67.42 million the same period last year.

Niu Technologies Q4 EPS $(0.06) Up From $(0.23) YoY, Sales $112.23M Up From $67.42M YoY

A new artificial intelligence framework developed by a Chinese start-up could reduce reliance on Nvidia Corp.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chips for AI model inference, marking the latest effort by Chinese tech companies to achieve technological self-sufficiency amid U.S. export restrictions.
What Happened: Qingcheng.AI, founded by Tsinghua University professor Zhai Jidong, unveiled &#8220;Chitu&#8221; &#8211; a high-performance inference framework for large language models that can operate on Chinese-made chips, <a href="https://www.scmp.com/tech/tech-war/article/3302516/chip-war-chinese-start-aims-break-nvidias-grip-ai-new-model-framework?module=perpetual_scroll_0&amp;pgtype=article">reported</a> South China Morning Post.
The open-source framework directly challenges Nvidia&#8217;s dominance in supporting advanced AI models like DeepSeek-R1, according to a joint statement released Friday.
When tested with DeepSeek-R1 using Nvidia&#8217;s A800 GPUs, Chitu achieved a 315% increase in model inference speed while reducing GPU usage by 50% compared to foreign frameworks, the company claimed.
The development comes amid heightened AI competition in China following DeepSeek&#8217;s breakthrough in January, which demonstrated high-performance models at significantly lower costs than U.S. competitors. DeepSeek&#8217;s success triggered a selloff in U.S. tech stocks, with Nvidia <a href="https://in.benzinga.com/markets/equities/25/02/43590545/nvidias-600-billion-sell-off-a-buying-opportunity-or-the-start-of-ai-market-disruption">losing $593 billion in market value</a> as investors feared increased competition.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44350195/ross-gerber-shares-peaceful-display-of-distaste-for-elon-musk-in-santa-monica-his-9-year-old-observes-glad-we-dont-have-a-tesla">Ross Gerber Shares &#8216;Peaceful Display Of Distaste For Elon Musk&#8217; In Santa Monica, His 9-Year Old Observes, &#8216;Glad We Don&#8217;t Have A Tesla&#8217;</a>
Why It Matters: Chinese tech giants are rapidly entering the race. Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) on Sunday unveiled ERNIE X1, <a href="https://in.benzinga.com/25/03/44349635/baidu-says-its-new-ai-is-smarter-than-deepseeks-and-costs-half-as-much-excellent-multimodal-understanding-ability">claiming performance comparable</a> to DeepSeek-R1 at half the price. Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) recently launched R1-Omni, an emotion-reading <a href="https://www.benzinga.com/markets/equities/25/03/44296725/alibaba-launches-ai-that-reads-emotions-to-rival-openai-but-shares-falls-on-hong-kong-exchange-despite-joe-tsais-10-trillion-market-outlook">AI model available for free</a>.
These initiatives reflect China&#8217;s broader push for technological independence after Washington banned sales of Nvidia&#8217;s advanced H100 and H800 chips to China-based clients. Backed by Beijing&#8217;s municipal AI fund, Qingcheng.AI has partnered with top Chinese GPU manufacturers including Moore Threads, Enflame and Iluvatar CoreX.
The AI surge has reignited investor interest in Chinese tech, potentially reversing three years of venture capital decline. &#8220;People are rushing just to find the next DeepSeek,&#8221; said Annabelle Yu Long, founding partner of BAI Capital, as the Chinese government <a href="https://in.benzinga.com/markets/25/03/44268864/chinese-investors-rushing-to-find-the-next-deepseek-says-vc-as-ai-boom-fuels-investment-surge-after-nvidia-selloff">prepares a fund expected</a> to mobilize 1 trillion yuan ($137.7 billion) for tech investment.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44348859/trump-says-he-was-little-bit-sarcastic-when-he-said-he-would-end-the-russia-ukraine-war-in-a-day-what-i-really-mean-is" target="_blank" rel="noreferrer noopener">Trump Says He Was ‘Little Bit Sarcastic&#8217; When He Said He Would End The Russia-Ukraine War In A Day: ‘What I Really Mean Is…&#8217;</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Startups

BABA

BIDU

NVDA

Nvidia Faces New AI Challenge As Chinese Start-Up Unveils Framework To Cut Reliance On Its GPUs

Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)  is reportedly in advanced talks with the White House to oversee the U.S. operations of TikTok, as concerns continue to mount over the app&#8217;s Chinese origins.
What Happened: Vice President JD Vance and National Security Adviser Mike Waltz are spearheading the discussions. The role of TikTok&#8217;s Chinese founders in its U.S. operations remains a significant point of concern, according <a href="https://www.politico.com/news/2025/03/16/white-house-oracle-tiktok-00232302">to</a> a Politico report. 
The proposed deal, dubbed &#8220;Project Texas 2.0&#8221;, is a sequel to an earlier agreement that saw TikTok and Oracle move American users&#8217; data to Texas-based servers. Despite this move, fears linger that China could exploit the app for espionage.
Oracle plans to meet with lawmakers, including Republicans, this week to discuss the proposed deal and growing national security concerns. Tech news outlet, The Information, reported that Oracle is a strong candidate to manage TikTok, with ByteDance, the app&#8217;s Beijing-based parent company, showing a preference for it.
The Chinese government has the ultimate authority to decide whether ByteDance sells TikTok or grants a U.S. company a license to operate it, as it seeks to maintain TikTok&#8217;s exclusive control over its user data.
SEE ALSO: <a href="https://www.benzinga.com/personal-finance/25/03/44346635/kevin-o-leary-says-elon-musk-will-walk-away-mid-conversation-if-he-gets-bored-he-doesnt-give-a-sht-ive-never-met-anybody-like-him">Kevin O&#8217; Leary Says Elon Musk Will Walk Away Mid Conversation If He Gets Bored, He &#8216;Doesn&#8217;t Give A Sh&#x2A;t&#8217;— &#8216;I&#8217;ve Never Met Anybody Like Him&#8217;</a>
Why It Matters: This development follows a recent announcement by Vice President JD Vance that a deal to maintain TikTok&#8217;s U.S. operations under American ownership is <a href="https://www.benzinga.com/25/03/44345433/tiktok-ban-deadline-looms-but-vice-president-jd-vance-confirms-high-level-us-ownership-deal-is-nearly-done">nearing completion</a>. 
This statement came ahead of the April 5 deadline set by a Biden-administration law, which mandates ByteDance to either sell TikTok on national security grounds or face a ban. The app experienced a temporary outage for approximately 12 hours in January after TikTok's parent company, ByteDance, missed the deadline to sell its stake, and the Supreme Court upheld Congress' ban.
Last Week, President Donald Trump confirmed that the administration had been in discussions with <a href="https://www.benzinga.com/markets/25/03/44213698/us-courts-new-buyers-for-tiktok-as-deal-deadline-approaches-all-four-are-good-says-trump">four different groups </a>regarding the sale of TikTok. In January, Trump had informed reporters that he was open to Oracle founder and executive chairman Larry Ellison purchasing TikTok. Ellison is also a part of Trump&#8217;s $500 billion&nbsp;Stargate AI project.
Oracle Corporation stock surged nearly 17% over the past year to close at $149.27 on Friday, as per <a href="http://v">Benzinga Pro</a>
READ MORE:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44350195/ross-gerber-shares-peaceful-display-of-distaste-for-elon-musk-in-santa-monica-his-9-year-old-observes-glad-we-dont-have-a-tesla">Ross Gerber Shares &#8216;Peaceful Display Of Distaste For Elon Musk&#8217; In Santa Monica, His 9-Year Old Observes, &#8216;Glad We Don&#8217;t Have A Tesla&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

ORCL

Oracle In Talks With White House To Oversee US Operations Of TikTok As Part Of Project Texas 2.0: Report

<ul>
<li>The AI-focused event, held at the Company's Los Angeles headquarters, consisted of AI experts, panel guests, potential future AI talents and FF employees, and showcased the Company's current and future AI strategy developments.</li>
<li>The new ‘Future AIHER' subsidiary is dedicated to the commercialization and development of both AI extended range and AI hybrid extended-range electric powertrain systems and solutions for both FF and potential future FX models and to other automotive OEMs, as well as air, ground, and ocean applications, such as electric vertical takeoff and landing (EVTOL) aircraft, commercial trucking, and electric boating industries.</li>
<li>FF and FX could offer up to three different powertrain systems: battery electric, range extended, and a super AI hybrid extended-range system designed specifically for U.S. consumers.</li>
</ul>

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Faraday Future Expands EV Innovation With Formation Of Future AIHER Subsidiary And Debuts AI Strategy at Company's First Open AI Day

EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium.
AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, and up to $575m in contingent consideration based on development and regulatory milestones.
The transaction is expected to close in the second quarter of 2025, subject to customary closing conditions and regulatory clearances.

AstraZeneca To Acquire EsoBiotec For Up To $1B, Advancing In Vivo Cell Therapy Capabilities With Breakthrough ENaBL Platform

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is reportedly entering its annual Top 100 executive retreat this week. This comes amid <a href="https://in.benzinga.com/media/25/03/44207932/apple-delays-next-gen-siri-its-going-to-take-us-longer-than-we-thought-to-deliver-ai-upgrades">mounting criticism over</a> the company's stalled artificial intelligence efforts.
What Happened: Since the era of Steve Jobs, this annual March gathering brings together Apple&#8217;s 100 most influential executives, reported Bloomberg's Mark Gurman in his latest weekly "Power On" newsletter.&nbsp;&nbsp;
He also called out top executives including CEO Tim Cook, marketing heads Greg Joswiak and Bob Borchers, software chief Craig Federighi, and AI lead John Giannandrea, saying all share <a href="https://www.benzinga.com/tech/25/03/44068020/apples-ai-crisis-falling-behind-in-the-ai-race">blame for the failure to deliver</a>.
See Also:&nbsp;<a href="https://www.benzinga.com/25/03/44069535/anthropic-ceo-dario-amodei-pushes-for-stronger-us-ai-safeguards-saying-autocracies-like-china-and-russia-could-use-ai-to-expand-their-power" target="_blank" rel="noreferrer noopener">Jeff Bezos-Backed Anthropic Pushes For Stronger US AI Safeguards, Saying Autocracies Like China, Russia Could Use AI To Expand Their Power</a>
&#8220;Given the nature of this collective failure, it's unlikely to result in management changes on Cook's executive team. That would mean admitting fault, which Apple hates doing,&#8221; Gurman said.
Previously, it was reported that Apple's Siri chief Robby Walker <a href="https://in.benzinga.com/25/03/44345486/apple-scrambles-to-fix-siris-ugly-and-embarrassing-ai-failures-after-public-missteptop-executive-admits-marketing-it-too-soon-made-things-worse">described the situation</a> as embarrassing, ugly and disappointing, blaming the early marketing push for features that weren't ready.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It's Important: Apple's <a href="https://www.benzinga.com/news/24/07/39665558/apples-most-awaited-siri-ai-upgrade-will-not-come-until-2025-report">long-promised Apple Intelligence</a> — including major upgrades to Siri — is in disarray, with features delayed indefinitely and internal frustration mounting.&nbsp;
Apple is under growing pressure to catch up in the AI race as rivals like OpenAI, Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, Meta Platforms, Inc. (NASDAQ:&nbsp; META), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) advance rapidly.
Apple&#8217;s AI setbacks coincide with a 12.45% drop in its stock value this year. Last week, Morgan Stanley expressed concerns about the company&#8217;s AI delays, lowering its <a href="https://in.benzinga.com/analyst-ratings/analyst-color/25/03/44284821/apple-stock-takes-a-bite-out-of-investors-as-siri-fumbles-ai-race">price target from $275 to $252</a>.
Price Action: Apple shares ended Friday at $213.49, gaining 1.82% during the session. However, in after-hours trading, the stock dipped slightly by 0.07%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Image via Shutterstock
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/03/44344993/apple-reportedly-fights-uk-governments-unacceptable-encryption-order-behind-closed-doors-no-press-or-public-allowed" target="_blank" rel="noreferrer noopener">Apple Reportedly Fights UK Government's ‘Unacceptable' Encryption Order Behind Closed Doors — No Press Or Public Allowed</a></li>
</ul>

Media

AAPL

AMZN

GOOG

GOOGL

MSFT

Apple's AI Crisis Reaches Boiling Point Ahead Of Top 100 Executive Retreat — Tim Cook And Key Execs Called Out Over Siri Failure By Top Analyst

<ul>
<li>Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with ELAHERE compared to chemotherapy in folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC)
<ul>
<li>Data presented in a late-breaking oral presentation at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Seattle</li>
</ul>
</li>
</ul>

ABBV

Reported Saturday, AbbVie Highlights Final MIRASOL Results At SGO 2025 Showing Clinically Meaningful Survival Gains With ELAHERE In Platinum-Resistant Ovarian Cancer

Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) led by the Oracle of Omaha, Warren Buffett, is in <a href="https://www.benzinga.com/ma/25/03/44317138/warren-buffetts-real-estate-brokerage-compass-discuss-deal-report">talks to sell</a> its real estate brokerage business to New York-based Compass Real Estate. While some experts view this as his levered bet against the U.S. home prices, others see it as a consolidation in the realty sector.
What Happened: Compass has offered to buy Berkshire&#8217;s realty business, HomeServices of America, including Real Living, for an undisclosed price, according to a WSJ <a href="https://www.wsj.com/real-estate/compass-in-talks-to-buy-warren-buffetts-real-estate-brokerage-unit-5eab82e5">report</a>. The Berkshire business has about 820 offices and 270 franchises, whereas Compass is the second-largest U.S. brokerage.
After these reports emerged, billionaire investor Chamath Palihapitiya took to X and said that &#8220;The world's best investor is selling his bet levered to US home prices.&#8221;
However, there wasn&#8217;t a consensus on the fact that a bet against a traditional brokerage is the same as betting against the U.S. home prices. According to Amy Nixon, a DFW housing and economic analyst, the possible sale of Berkshire&#8217;s realty business to Compass was &#8220;not necessarily a bet against US home prices,&#8221; because Buffett could be betting on the real estate technology to reshape the industry further.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">He dumped all his home builder stocks a year ago and that proved wise That said, a bet against a traditional brokerage is not necessarily a bet against US home prices He may be betting on REtech reshaping the industry even further
&mdash; Amy Nixon (@texasrunnerDFW) <a href="https://twitter.com/texasrunnerDFW/status/1901335669978390537?ref_src=twsrc%5Etfw">March 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/03/44298732/nvidia-valuation-drops-after-2025-rout-ai-chipmakers-price-declines-41-from-its-peak-when-chatgpt-was-launched">Nvidia Valuation Drops After 2025 Rout: Chipmaker&#8217;s Price Declines 41% From Its Peak When ChatGPT Was Launched</a>
Why It Matters: Despite a sale of its business having any correlation with a bet on U.S. home prices, as mentioned by Nixon. The impact of higher interest rates does affect the housing market. Higher interest rates strain both homebuyers, facing increased monthly payments, and sellers, experiencing reduced demand and lower offers.
The Federal Reserve&#8217;s primary monetary policy-making body, the Federal Open Market Committee, is scheduled to meet on March 18 and 19 this week to decide on the course of interest rates.
According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 99% chance that the Federal Reserve will keep interest rates unchanged for the March meeting. However, the probability of an ease increases from June 2025 onwards. 
Furthermore, the U.S. real estate sector is consolidating, as Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) signed an <a href="https://www.benzinga.com/ma/25/03/44317138/warren-buffetts-real-estate-brokerage-compass-discuss-deal-report">acquisition deal</a> worth $1.75 billion last week with Redfin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>).
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose on Friday. The SPY was advanced 2.07% to $562.81, and the QQQ also jumped 2.42% to $479.66, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44299872/jack-dorseys-block-first-us-company-to-deploy-nvidias-ai-cluster-predicts-30x-performance-boost">Jack Dorsey&#8217;s Block First US Company To Deploy Nvidia&#8217;s AI Cluster, Predicts 30x Performance Boost</a></li>
</ul>
Photo courtesy: Shutterstock

RDFN

Warren Buffett Plans To Sell His Real Estate Brokerage, But It's 'Not… A Bet Against US Home Prices,' Says Analyst As Fed Expects To Keep Rates Unchanged

Reported Saturday, Rocket Lab Successfully Deploys Third Pioneer Spacecraft To Orbit, Powering Varda's Latest In-Space Pharmaceutical Manufacturing Mission

<ul>
<li>Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate an objective response rate (ORR) of ~35% in response-evaluable patients</li>
<li>On track to initiate Part 2 of the ongoing DENALI clinical trial in 1H 2025, with registration-intent topline data anticipated by year end 2026</li>
<li>Company also presents preclinical combination data of azenosertib with microtubule inhibitor-based antibody-drug conjugates (ADCs), demonstrating synergistic antitumor effects</li>
</ul>

ZNTL

Reported Saturday, Zentalis Presented Updated DENALI Part 1b Clinical Data Demonstrating 6.3-Month mDOR And ~35% ORR With Azenosertib Monotherapy In Cyclin E1+ Platinum-Resistant Ovarian Cancer

Press Releases

BioCardia Regains Full Compliance with Nasdaq Listing Requirements

Health Care

BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure

BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024

BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results

BioCardia Announces Positive Consultation with Japan PMDA on CardiAMP Cell Therapy for Ischemic Heart Failure

General

BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family

BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions

BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF)

BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions

Comments

BioCardia

BioCardia (BCDA) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL